Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Little is known about the mechanisms involved in the dysfunction of melanocytes in vitiligo epidermis. It is hypothesized that some cytokine/receptor interactions may be affected, resulting in dysfunction and/or loss of melanocytes. This study has compared the expression of endothelin (ET)-1, the ET-1 receptor (ET(B)R), granulocyte macrophage colony stimulating factor (GM-CSF), stem cell factor (SCF), the SCF receptor (KIT protein), tyrosinase, and S100 alpha between lesional and non-lesional vitiligo epidermis. Analysis by reverse transcription-polymerase chain reaction (RT-PCR) and by western blotting for ET-1 and SCF unexpectedly demonstrated up-regulated expression of these cytokines in lesional vitiligo epidermis. Immunohistochemistry with antibodies to melanocyte markers revealed that at the edge of the lesional epidermis, melanocytes remain and express tyrosinase, S100 alpha and ET(B)R, but not KIT protein or melanocyte-specific microphthalmia-associated transcription factor (MITF-M). Quantitation of the staining revealed a slight or moderate decrease in the number of S100 alpha, tyrosinase, and ET(B)R-positive cells at the edge of the lesional epidermis. In contrast, the number of cells expressing KIT protein was markedly decreased at the edge of the lesional epidermis compared with the non-lesional epidermis. At the centre of the lesional epidermis, there was complete loss of melanocytes expressing KIT protein, S100 alpha, ET(B)R, and/or tyrosinase. Western blotting revealed down-regulated expression of c-kit and MITF-M proteins at the edge of the lesional epidermis in vitiligo. These findings suggest that reduction in the expression of KIT protein by melanocytes and its downstream effectors, including MITF-M, may be associated with the dysfunction and/or loss of melanocytes in vitiligo epidermis.
Kitamura
Reiko
R
Department of Dermatology, University of Yamanashi, Faculty of Medicine, Yamanashi, Japan.
Tsukamoto
Katsuhiko
K
Harada
Kazutoshi
K
Shimizu
Akira
A
Shimada
Shinji
S
Kobayashi
Takeshi
T
Imokawa
Genji
G
D000328:Adult; D000368:Aged; D000918:Antibody Specificity; D015153:Blotting, Western; D004268:DNA-Binding Proteins / Q000276:immunology / Q000378:metabolism; D019332:Endothelin-1 / Q000235:genetics / Q000378:metabolism; D004817:Epidermis / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008297:Male; D008544:Melanocytes / Q000502:physiology*; D051739:Microphthalmia-Associated Transcription Factor; D008875:Middle Aged; D015513:Oncogene Proteins / Q000378:metabolism*; D019009:Proto-Oncogene Proteins c-kit; D012333:RNA, Messenger / Q000235:genetics; D044022:Receptor, Endothelin A / Q000276:immunology / Q000378:metabolism; D019089:Stem Cell Factor / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000276:immunology / Q000378:metabolism; D014820:Vitiligo / Q000378:metabolism* / Q000473:pathology
D004268:DNA-Binding Proteins; D019332:Endothelin-1; C497234:MITF protein, human; D051739:Microphthalmia-Associated Transcription Factor; D015513:Oncogene Proteins; D012333:RNA, Messenger; D044022:Receptor, Endothelin A; D019089:Stem Cell Factor; D014157:Transcription Factors; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D019009:Proto-Oncogene Proteins c-kit